Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Keryx Biopharmaceuticals Appoints VP, Marketing And Strategy

Executive Summary

Keryx Biopharmaceuticals Inc., a biopharma specialising in the treatment of renal disease, has appointed Douglas Jermasek vice president of marketing and strategy. Jermasek has more than 20 years of biopharma strategic marketing experience, having held senior leadership roles at several companies, including Deltanoid Pharmaceuticals, Intercept Pharmaceuticals and Genzyme/Sanofi’s global renal business, where he reached the position of senior vice president and general manager. 

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

SC065549

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel